HUMA
Price
$2.59
Change
-$0.03 (-1.15%)
Updated
Jun 6 closing price
Capitalization
406.41M
72 days until earnings call
JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
Capitalization
517.74M
Interact to see
Advertisement

HUMA vs JBPHF

Header iconHUMA vs JBPHF Comparison
Open Charts HUMA vs JBPHFBanner chart's image
Humacyte
Price$2.59
Change-$0.03 (-1.15%)
Volume$6.64M
Capitalization406.41M
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
Capitalization517.74M
HUMA vs JBPHF Comparison Chart
Loading...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HUMA vs. JBPHF commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUMA is a Buy and JBPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (HUMA: $2.63 vs. JBPHF: $0.29)
Brand notoriety: HUMA and JBPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HUMA: 85% vs. JBPHF: 100%
Market capitalization -- HUMA: $406.41M vs. JBPHF: $517.74M
HUMA [@Biotechnology] is valued at $406.41M. JBPHF’s [@Biotechnology] market capitalization is $517.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HUMA’s FA Score shows that 0 FA rating(s) are green whileJBPHF’s FA Score has 1 green FA rating(s).

  • HUMA’s FA Score: 0 green, 5 red.
  • JBPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HUMA and JBPHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HUMA’s TA Score shows that 5 TA indicator(s) are bullish.

  • HUMA’s TA Score: 5 bullish, 4 bearish.

Price Growth

HUMA (@Biotechnology) experienced а +12.39% price change this week, while JBPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

HUMA is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBPHF($518M) has a higher market cap than HUMA($406M). JBPHF YTD gains are higher at: 0.000 vs. HUMA (-47.921).
HUMAJBPHFHUMA / JBPHF
Capitalization406M518M78%
EBITDA-137.16MN/A-
Gain YTD-47.9210.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash20.6MN/A-
Total Debt17.3MN/A-
TECHNICAL ANALYSIS
Technical Analysis
HUMA
RSI
ODDS (%)
Bearish Trend 12 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
77%
Aroon
ODDS (%)
Bullish Trend 12 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with KYMR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
+6.05%
KYMR - HUMA
38%
Loosely correlated
+2.35%
RXRX - HUMA
38%
Loosely correlated
+0.11%
ACRV - HUMA
37%
Loosely correlated
N/A
AURA - HUMA
36%
Loosely correlated
+0.17%
PRLD - HUMA
36%
Loosely correlated
+8.80%
More

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been loosely correlated with DTIL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if JBPHF jumps, then DTIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
DTIL - JBPHF
47%
Loosely correlated
+1.64%
LVTX - JBPHF
38%
Loosely correlated
+2.33%
BIVI - JBPHF
31%
Poorly correlated
-0.95%
MIST - JBPHF
31%
Poorly correlated
+7.04%
HUMA - JBPHF
30%
Poorly correlated
+6.05%
More